4 days Why Enliven is this analyst’s top biotech stock pickYouTube Why Enliven is this analyst’s top biotech stock pick. Biotech X
6 hours Cabaletta: Biotech With Large Potential, Interesting Bottom Pattern, Plenty Of CashSeeking Alpha X
12 hours Everence Capital Management Inc. Invests $557,000 in Krystal Biotech, Inc. (NASDAQ:KRYS)MarketBeat X
5 days Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Rating of “Buy” from BrokeragesMarketBeat X
5 days Sage Therapeutics’ stock falls 4.7% as biotech unveils plan to cut 33% of workforceMarketWatch X
6 days Is Novo Nordisk A/S (NVO) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X
6 days Is Cytokinetics Inc. (CYTK) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X
6 days Is Neurocrine Biosciences, Inc. (NBIX) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X
6 days Is Sarepta Therapeutics, Inc. (SRPT) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X
6 days Is Jazz Pharmaceuticals plc (JAZZ) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X
6 days Moderna, Inc. (MRNA) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X
6 days Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X
6 days Is CRISPR Therapeutics AG (CRSP) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X
6 days Is Legend Biotech Corporation (LEGN) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X
6 days Is Taysha Gene Therapies, Inc. (TSHA) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X
6 days Small-cap biotech Jaguar Health’s stock jumps as it launches treatment for a painful side effect of cancer treatmentMarketWatch X
7 days Oncolytics Biotech (TSE:ONC) Stock Price Crosses Above 200-Day Moving Average – What’s Next?MarketBeat X
1 week Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A RecordInvestor's Business Daily X
1 week Q2 2025 EPS Estimates for Blueprint Medicines Co. Boosted by Analyst (NASDAQ:BPMC)MarketBeat X
1 week Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit TherapeuticsThe Motley Fool X
1 week Shaker Investments LLC OH Takes $532,000 Position in Krystal Biotech, Inc. (NASDAQ:KRYS)MarketBeat X
2 weeks Cubist Systematic Strategies LLC Invests $2.62 Million in Legend Biotech Co. (NASDAQ:LEGN)MarketBeat X
2 weeks U.S. IPO Weekly Recap: Active IPO Market Continues With KinderCare And Trio Of Biotech DealsSeeking Alpha X
2 weeks Novo and Eli contender Zealand Pharma heralds its obesity drug alternative: It’s our ‘crown jewel’CNBC X
2 weeks The Biotech Growth Trust (LON:BIOG) Share Price Passes Below 50-Day Moving Average – Should You Sell?MarketBeat X
2 weeks Prediction: This Will Be the Best-Performing Growth Stock Over the Next 5 Years24/7 Wall St. X
2 weeks Analysts Rate Centessa Pharmaceuticals Plc (CNTA) as Strong Buy Amid Promising DevelopmentsInsider Monkey X
2 weeks Wall Street Analysts Rate Geron Corporation (GERN) as a Buy Amid Strong Growth ProspectsInsider Monkey X
2 weeks RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 LetterInsider Monkey X
2 weeks Analysts Rate Cogent Biosciences, Inc. (COGT) as Moderate Buy with $15 TargetInsider Monkey X
2 weeks Strong Investor Sentiment: Artisan Partners Highlights Iovance Biotherapeutics, Inc. (IOVA)Insider Monkey X
2 weeks BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2Insider Monkey X
2 weeks Travere Therapeutics, Inc. (TVTX) Increases R&D Investments Amidst Rising Product SalesInsider Monkey X
2 weeks Sage Therapeutics’ stock slides after biotech says it will cease development of Alzheimer’s treatmentMarketWatch X
2 weeks Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by The Manufacturers Life Insurance CompanyMarketBeat X
2 weeks Handelsbanken Fonder AB Sells 11,800 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)MarketBeat X
2 weeks BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Acquired by AQR Capital Management LLCMarketBeat X
2 weeks Kymera’s Protein Degradation Technology: A Promising Bet For Long-Term Biotech InvestorsSeeking Alpha X
3 weeks A microbial extract from Finnish forests can heal eczema, a biotech startup saysThe Next Web X
3 weeks Shattuck Labs’ stock craters as biotech scraps main product candidate after failed trialMarketWatch X
3 weeks Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite MakeoverInvestor's Business Daily X
3 weeks Stonepine Capital Management LLC Takes $1.71 Million Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)MarketBeat X
3 weeks Point72 Asset Management L.P. Buys New Position in Legend Biotech Co. (NASDAQ:LEGN)MarketBeat X